Status:
COMPLETED
Preemie Prep For Parents (P3): Home Antenatal Prematurity Education
Lead Sponsor:
Medical College of Wisconsin
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Premature Birth
Decision Making
Eligibility:
All Genders
Phase:
NA
Brief Summary
The Preemie Prep for Parents (P3) mobile intervention will be tested in an outpatient population of pregnant women at risk of preterm birth and their partners. The study is a randomized controlled tri...
Detailed Description
This is a randomized controlled study focused on an outpatient population of pregnant women at risk of preterm birth and their partners. The objective is to test the efficacy of the Preemie Prep for P...
Eligibility Criteria
Inclusion
- Pregnant woman or her partner
- At risk for preterm birth, as indicated by: history of spontaneous preterm birth (during the 34th week or earlier), shortened cervical length, multiple gestation, fetal growth restriction, chronic hypertension, history of preeclampsia, and/or diabetes requiring medications.
- Gestational age of 16-21 weeks at recruitment.
- Owns a smartphone.
- Able to speak English
Exclusion
- • Pregnancies with known significant birth defects.
Key Trial Info
Start Date :
February 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
175 Patients enrolled
Trial Details
Trial ID
NCT04093492
Start Date
February 3 2020
End Date
January 31 2022
Last Update
March 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Froedtert Hospital
Milwaukee, Wisconsin, United States, 53226